References
- McDonald K, Shelley A, Alavi A. A systematic review on oral isotretinoin therapy and clinically observable wound healing in acne patients. J Cutan Med Surg. 2017;21:325–33. doi:10.1177/1203475417701419.
- Bagatin E. Oral isotretinoin: the most promising dermatological off-label uses. Expert Rev Dermatol. 2010;5:617–26. doi:10.1586/edm.10.58.
- Spring LK, Krakowski AC, Alam M, Bhatia A, Brauer J, Cohen J, Del Rosso JQ, Diaz L, Dover J, Eichenfield LF, et al. Isotretinoin and timing of procedural interventions: a systematic review with consensus recommendations. JAMA Dermatol. 2017;153:802–09. doi:10.1001/jamadermatol.2017.2077.
- CLARUS Product Monograph. MYLAN Pharmaceuticals ULC. Last revision: November 18, 2013. Retrieved from: http://www.clarusclearprogram.ca/PDFs/Clarus%20Product%20Monograph.pdf
- ACCUTANE Product Monograph. Hoffmann-La Roche Limited. Last revision November 29, 2016. Retrieved from: http://www.rochecanada.com/content/dam/roche_canada/en_CA/documents/Research/ClinicalTrialsForms/Products/ConsumerInformation/MonographsandPublicAdvisories/Accutane/Accutane_PM_E.pdf
- Prather H, Alam M, Poon E, Arndt KA, Dover JS. Laser safety in isotretinoin use: a survey of expert opinion and practice. Dermatol Surg. 2017;43:357–63. doi:10.1097/DSS.0000000000001019.
- Waldman A, Dolotin D, Arndt KA, Dover JS, Geronemus RG, Chapas A, Iyengar S, Kilmer SL, Krakowski AC, Lawrence N, Prather HB, Rohrer TE, Schlosser BJ, Kim JYS, Shumaker PR, Spring LK, Alam M. ASDS Guidelines Task Force: consensus recommendations regarding the safety of lasers, dermabrasion, chemical peels, energy devices, and skin surgery during and after isotretinoin use. Dermatol Surg. 2017: ePub. doi:10.1097/DSS.0000000000001166.
- Tolkachjov AN, Sahoo A, Patel NG, Lohse CM, Murray JA, Tollefson MM. Surgical outcomes of patients on isotretinoin in the perioperative period: a single-center, retrospective analysis. J Am Acad Dermatol. 2017;77:159–61. doi:10.1016/j.jaad.2017.03.019.